TOBRAMYCIN AND DEXA
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F9624 to DMS Pharmaceutical Group Inc on September 8, 2026. This award serves as a delivery order under the base administration contract SPE2DX25D9900 and was issued by the DLA Troop Support Medical Supply Chain Pharm FSA. The procurement is for the supply of Tobramycin and Dexa, identified by National Stock Number 6505013041008 and part number NDC61314-0647-05. The contract specifies a unit price of 10.83 dollars with a total payable amount of 21.00 dollars. The terms include inspection and acceptance at the destination and are established as FOB destination. This order is part of a broader commercial items framework and adheres to standard federal acquisition regulations, including clauses related to combating trafficking in persons.
General Info
Contract Value
$10.83Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
